17561-26-1 Usage
Uses
Used in Pharmaceutical Industry:
(S)-(-)-2-Chloro-3-[4(5)-imidazolyl]propionic Acid is used as a TAFIa inhibitor for its potential application in the development of therapeutic agents targeting coagulation and fibrinolysis-related disorders. By inhibiting TAFIa, this compound may help in the treatment of conditions such as thrombosis, deep vein thrombosis, and other clot-related diseases.
Additionally, due to its chemical properties and structure, (S)-(-)-2-Chloro-3-[4(5)-imidazolyl]propionic Acid may also find applications in other industries, such as:
Used in Chemical Synthesis Industry:
(S)-(-)-2-Chloro-3-[4(5)-imidazolyl]propionic Acid can be used as a building block or intermediate in the synthesis of more complex molecules, potentially leading to the development of new drugs or materials with various applications.
Used in Research and Development:
As a substituted imidazole, (S)-(-)-2-Chloro-3-[4(5)-imidazolyl]propionic Acid may be utilized in academic and industrial research settings to study its properties, interactions, and potential applications in various fields, including medicinal chemistry, materials science, and biotechnology.
Check Digit Verification of cas no
The CAS Registry Mumber 17561-26-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,5,6 and 1 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 17561-26:
(7*1)+(6*7)+(5*5)+(4*6)+(3*1)+(2*2)+(1*6)=111
111 % 10 = 1
So 17561-26-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H7ClN2O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1H2,(H,8,9)(H,10,11)/t5-/m0/s1
17561-26-1Relevant articles and documents
Histidine derivatives as tridentate chelators for the fac-[M I(CO)3] (Re, 99mTc, 188Re) core: Synthesis, structural characterization, radiochemistry and stability
Papagiannopoulou, Dionysia,Tsoukalas, Charalambos,Makris, George,Raptopoulou, Catherine P.,Psycharis, Vassilis,Leondiadis, Leondios,Gdniazdowska, Ewa,Kozminski, Przemyslaw,Fuks, Leon,Pelecanou, Maria,Pirmettis, Ioannis,Papadopoulos, Minas S.
, p. 333 - 337 (2011)
The development of new rhenium(I)- and technetium(I)-tricarbonyl complexes can lead to potentially useful radiopharmaceuticals. In this work, the synthesis of the neutral rhenium complex fac-[Re(NSO)(CO)3], Re-1, where NSO is the tridentate che
Efficient preparation of urocanic acid derivatives from histidine
Lovely, Carl J.,Sivappa, Rasapalli,Mukherjee, Sabuj,Doundoulakis, Thomas,Lima, Heather M.,Yousufuddin, Muhammed
scheme or table, p. 1353 - 1358 (2010/10/20)
Urocanic acid derivatives have served as useful starting materials in several total synthesis endeavors in our lab. This paper describes a convenient, large-scale synthesis of several derivatives of urocanic acid via the net elimination of ammonia from hi
